ArticleTranslational lung cancer research2024

Dual immuno-oncology agents as neoadjuvant therapy for patients with resectable non-small cell lung cancer.

Hiroyuki Adachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.